Peer Review reports
From: OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
| Original Submission | ||
|---|---|---|
| 21 Mar 2022 | Submitted | Original manuscript |
| 28 Mar 2022 | Reviewed | Reviewer Report |
| 9 Apr 2022 | Reviewed | Reviewer Report |
| 16 Jun 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 2 | ||
| 16 Jun 2022 | Submitted | Manuscript version 2 |
| 19 Jul 2022 | Reviewed | Reviewer Report |
| 21 Jul 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 3 | ||
| 21 Jul 2022 | Submitted | Manuscript version 3 |
| 3 Aug 2022 | Reviewed | Reviewer Report |
| 29 Aug 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 4 | ||
| 29 Aug 2022 | Submitted | Manuscript version 4 |
| 9 Sep 2022 | Reviewed | Reviewer Report |
| 12 Sep 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 5 | ||
| 12 Sep 2022 | Submitted | Manuscript version 5 |
| 28 Oct 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 6 | ||
| 28 Oct 2022 | Submitted | Manuscript version 6 |
| 18 Nov 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
| Resubmission - Version 7 | ||
| 18 Nov 2022 | Submitted | Manuscript version 7 |
| Publishing | ||
| 24 Nov 2022 | Editorially accepted | |
| 6 Dec 2022 | Article published | 10.1186/s12890-022-02264-9 |
You can find further information about peer review here.